Medication

Semaglutide

Semaglutide is a GLP-1 receptor agonist used for weight loss and glycemic control.

Semaglutide is a long-acting GLP-1 receptor agonist administered weekly by subcutaneous injection. It supports weight loss and glycemic control and is prescribed at REVRCEL in compounded form under physician oversight, with quarterly metabolic bloodwork.

Related terms

GLP-1 (Glucagon-Like Peptide-1)Tirzepatide

Statements have not been evaluated by the FDA. Educational content only; not medical advice.